Top

Published in:

01-10-2013 | Head and Neck Oncology

Clinical Nodal Stage is a Significant Predictor of Outcome in Patients with Oral Cavity Squamous Cell Carcinoma and Pathologically Negative Neck Metastases: Results of the International Consortium for Outcome Research

Authors: M. Amit, MD, MSc, T. C. Yen, MD, C. T. Liao, MD, PhD, Y. Binenbaum, MD, P. Chaturvedi, MD, J. P. Agarwal, MD, PhD, L. P. Kowalski, MD, A. Ebrahimi, MD, J. R. Clark, MD, C. R. Cernea, MD, S. J. Brandao, MD, M. Kreppel, MD, J. Zöller, MD, PhD, D. Fliss, MD, G. Bachar, MD, T. Shpitzer, MD, V. A. Bolzoni, MD, P. R. Patel, MD, S. Jonnalagadda, MD, K. T. Robbins, MD, J. P. Shah, MD, S. G. Patel, MD, Ziv Gil, MD, PhD, The International Consortium for Outcome Research (ICOR) in Head and Neck Cancer

Published in: Annals of Surgical Oncology | Issue 11/2013

Abstract

Background

We aimed to study the importance of clinical N classification (cN) in a subgroup of patients with oral cavity squamous cell carcinoma (OSCC) and pathologically negative neck nodes (pN−).

Methods

A total of 2,258 patients from 11 cancer centers who underwent neck dissection for OSCC (1990–2011) had pN− disease. The median follow-up was 44 months. 5-year overall survival (OS), disease-specific survival (DSS), disease free survival, local control, locoregional control, and distant metastasis rates were calculated by the Kaplan–Meier method. cN classification and tumor, node, metastasis classification system staging variables were subjected to multivariate analysis.

Results

A total of 345 patients were preoperatively classified as cN+ and 1,913 were classified as cN−. The 5-year OS and DSS of cN− patients were 73.6 and 82.2 %, respectively. The 5-year OS and DSS of cN+ patients were 64.9 and 76.9 %, respectively (p < 0.0001 each). A cN+ classification was a significant predictor of worse OS (p = 0.03) and DSS (p = 0.016), regardless of treatment, depth of invasion, or extent of neck dissection. cN classification was associated with recurrence-free survival (p = 0.01) and locoregional (neck and primary tumor) control (p = 0.004), but not with local (p = 0.19) and distant (p = 0.06) recurrence rates.

Conclusions

Clinical evidence of neck metastases is an independent predictor of outcome, even in patients with pN− nodes.

Available only for authorised users

Shah JP, Gil Z. Current concepts in management of oral cancer—surgery. Oral Oncol. 2009;45:394–401.PubMedCrossRef

Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350:1945–52.PubMedCrossRef

Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350:1937–44.PubMedCrossRef

Rudoltz MS, Benammar A, Mohiuddin M. Does pathologic node status affect local control in patients with carcinoma of the head and neck treated with radical surgery and postoperative radiotherapy? Int J Radiat Oncol Biol Phys. 1995;31:503–8.PubMedCrossRef

Parsons JT, Mendenhall WM, Stringer SP, Cassisi NJ, Million RR. An analysis of factors influencing the outcome of postoperative irradiation for squamous cell carcinoma of the oral cavity. Int J Radiat Oncol Biol Phys. 1997;39:137–48.PubMedCrossRef

Gavilan J, Prim MP, De Diego JI, Hardisson D, Pozuelo A. Postoperative radiotherapy in patients with positive nodes after functional neck dissection. Ann Otol Rhinol Laryngol. 2000;109:844–8.PubMed

Jakobsen J, Hansen O, Jorgensen KE, Bastholt L. Lymph node metastases from laryngeal and pharyngeal carcinomas—calculation of burden of metastasis and its impact on prognosis. Acta Oncol. 1998;37:489–93.PubMedCrossRef

Matsuo JM, Patel SG, Singh B, et al. Clinical nodal stage is an independently significant predictor of distant failure in patients with squamous cell carcinoma of the larynx. Ann Surg. 2003;238:412–21.PubMed

Gil Z, Carlson DL, Boyle JO, et al. Lymph node density is a significant predictor of outcome in patients with oral cancer. Cancer. 2009;115:5700–10.PubMedCrossRef

10.

Robbins KT, Shaha AR, Medina JE, et al. Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg. 2008;134:536–8.PubMedCrossRef

11.

National Health Service. Yorkshire Cancer Network. Head and Neck Group. Guidelines for the examination and reporting of head and neck cancer specimens. 2007. http://www.yorkshire-cancer-net.org.uk/html/downloads/ycn-headneck-pathologyguidelines-july2010.pdf.

12.

Ebrahimi A, Zhang WJ, Gao K, Clark JR. Nodal yield and survival in oral squamous cancer: defining the standard of care. Cancer. 2011;117:2917–25.PubMedCrossRef

13.

Patel SG, Shah JP. TNM staging of cancers of the head and neck: striving for uniformity among diversity. CA Cancer J Clin. 2005;55:242–58.PubMedCrossRef

14.

von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–7.CrossRef

15.

Sackett DL. Bias in analytic research. J Chronic Dis. 1979;32:51–63.PubMedCrossRef

16.

Woolgar JA. Detailed topography of cervical lymph-note metastases from oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 1997;26:3–9.PubMedCrossRef

17.

Shingaki S, Takada M, Sasai K, et al. Impact of lymph node metastasis on the pattern of failure and survival in oral carcinomas. Am J Surg. 2003;185:278–84.PubMedCrossRef

18.

Shah JP, Candela FC, Poddar AK. The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity. Cancer. 1990;66:109–13.PubMedCrossRef

19.

Byers RM, Clayman GL, McGill D, et al. Selective neck dissections for squamous carcinoma of the upper aerodigestive tract: patterns of regional failure. Head Neck. 1999;21:499–505.PubMedCrossRef

20.

Gil Z, Fliss DM. Contemporary management of head and neck cancers. Isreal Med Assoc J. 2009;11:296–300.PubMed

21.

Kyzas PA, Evangelou E, Denaxa-Kyza D, Ioannidis JP. ¹⁸F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. J Natl Cancer Inst. 2008;100:712–20.PubMedCrossRef

22.

Merritt RM, Williams MF, James TH, Porubsky ES. Detection of cervical metastasis. A meta-analysis comparing computed tomography with physical examination. Arch Otolaryngol Head Neck Surg. 1997;123:149–52.PubMedCrossRef

23.

Koch WM, Ridge JA, Forastiere A, Manola J. Comparison of clinical and pathological staging in head and neck squamous cell carcinoma: results from Intergroup Study ECOG 4393/RTOG 9614. Arch Otolaryngol Head Neck Surg. 2009;135:851–8.PubMedCrossRef

24.

Ross GL, Soutar DS, MacDonald DG, Shoaib T, Camilleri IG, Robertson AG. Improved staging of cervical metastases in clinically node-negative patients with head and neck squamous cell carcinoma. Ann Surg Oncol. 2004;11:213–8.PubMedCrossRef

25.

Ambrosch P, Brinck U. Detection of nodal micrometastases in head and neck cancer by serial sectioning and immunostaining. Oncology (Williston Park). 1996;10:1221–6.PubMed

26.

Rhee D, Wenig BM, Smith RV. The significance of immunohistochemically demonstrated nodal micrometastases in patients with squamous cell carcinoma of the head and neck. Laryngoscope. 2002;112:1970–4.PubMedCrossRef

27.

Barrera JE, Miller ME, Said S, Jafek BW, Campana JP, Shroyer KR. Detection of occult cervical micrometastases in patients with head and neck squamous cell cancer. Laryngoscope. 2003;113:892–6.PubMedCrossRef

28.

Becker MT, Shores CG, Yu KK, Yarbrough WG. Molecular assay to detect metastatic head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2004;130:21–7.PubMedCrossRef

29.

Agrama MT, Reiter D, Topham AK, Keane WM. Node counts in neck dissection: are they useful in outcomes research? Otolaryngol Head Neck Surg. 2001;124:433–5.PubMedCrossRef

30.

Jose J, Coatesworth AP, MacLennan K. Cervical metastases in upper aerodigestive tract squamous cell carcinoma: histopathologic analysis and reporting. Head Neck. 2003;25:194–7.PubMedCrossRef

31.

Bhattacharyya N. The effects of more conservative neck dissections and radiotherapy on nodal yields from the neck. Arch Otolaryngol Head Neck Surg. 1998;124:412–6.PubMedCrossRef

32.

Gil Z, Even-Sapir E, Margalit N, Fliss DM. Integrated PET/CT system for staging and surveillance of skull base tumors. Head Neck. 2007;29:537–45.PubMedCrossRef

33.

Trimble EL, Abrams JS, Meyer RM, et al. Improving cancer outcomes through international collaboration in academic cancer treatment trials. J Clin Oncol. 2009;27:5109–14.PubMedCrossRef

34.

Bernier J, Cooper JS, Pajak TF, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck. 2005;27:843–50.PubMedCrossRef

Title: Clinical Nodal Stage is a Significant Predictor of Outcome in Patients with Oral Cavity Squamous Cell Carcinoma and Pathologically Negative Neck Metastases: Results of the International Consortium for Outcome Research
Authors: M. Amit, MD, MSc
T. C. Yen, MD
C. T. Liao, MD, PhD
Y. Binenbaum, MD
P. Chaturvedi, MD
J. P. Agarwal, MD, PhD
L. P. Kowalski, MD
A. Ebrahimi, MD
J. R. Clark, MD
C. R. Cernea, MD
S. J. Brandao, MD
M. Kreppel, MD
J. Zöller, MD, PhD
D. Fliss, MD
G. Bachar, MD
T. Shpitzer, MD
V. A. Bolzoni, MD
P. R. Patel, MD
S. Jonnalagadda, MD
K. T. Robbins, MD
J. P. Shah, MD
S. G. Patel, MD
Ziv Gil, MD, PhD
The International Consortium for Outcome Research (ICOR) in Head and Neck Cancer
Publication date: 01-10-2013
Publisher: Springer US
Published in: Annals of Surgical Oncology / Issue 11/2013
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-013-3044-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Clinical Nodal Stage is a Significant Predictor of Outcome in Patients with Oral Cavity Squamous Cell Carcinoma and Pathologically Negative Neck Metastases: Results of the International Consortium for Outcome Research

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 11/2013

Thermal Ablation Versus Repeated Hepatic Resection for Recurrent Intrahepatic Cholangiocarcinoma

Does Bethesda Category Predict Aggressive Features in Malignant Thyroid Nodules?

Noncurative Gastrectomy for Gastric Adenocarcinoma Should only be Performed in Highly Selected Patients

KRAS Mutations and Rectal Cancer Response to Chemoradiation: Are We Closer to Personalization of Therapy?

Safety of Liver Resection for Hepatocellular Carcinoma After Sorafenib Therapy: A Multicenter Case-Matched Study

Risk of Limited Lymph Node Dissection in Patients with Clinically Early Gastric Cancer: Indications of Extended Lymph Node Dissection for Early Gastric Cancer